Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists' jobs in the future and nailing GTM to reach a ~$1B valuation.
00:00 intro
01:01 pathology and AI
13:30 nailing go-to-market strategy
19:47 how pathology labs can go digital
25:36 regulatory frameworks and roadblocks
33:05 do improvements in foundation models impact PathAI?
36:26 standardizing diagnoses
40:05 how will the job of a pathologist change going forward?
42:35 NASH
47:30 working in Daphne Koller’s lab
